Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1701304

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1701304

Clinical Trial Central Laboratory Services Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Service, By Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Trial Central Laboratory Services Market Growth & Trends:

The global clinical trial central laboratory services market size is expected to reach USD 6.97 billion by 2030, growing at a CAGR of 9.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the increasing number of clinical trials, rising demand for biomarker-based testing, stringent regulatory requirements, and growing adoption of decentralized trials. Moreover, technological advancements such as AI-driven analytics, automation, and digital lab management systems further enhance efficiency, reduce turnaround times, and improve overall trial outcomes.

The market is expanding rapidly due to the increasing number of drug development programs and growing investments in research and development. Pharmaceutical and biotechnology companies are conducting more clinical trials to bring innovative therapies to market, further driving the demand for specialized laboratory services. Biomarker-based testing, genomic analysis, and pharmacokinetics studies are becoming essential for clinical trials, requiring advanced lab capabilities. Regulatory authorities are imposing stringent guidelines for drug approval, making centralized laboratory services critical for ensuring compliance, data accuracy, and standardized testing procedures.

Furthermore, the shift toward decentralized and virtual trials further transforms the industry, increasing the need for efficient sample collection, real-time data integration, and remote testing solutions. Emerging technologies such as AI-driven analytics, automation, and digital lab management systems enhance operational efficiency and accelerate trial timelines. Moreover, strategic collaborations between pharmaceutical companies, CROs, and central lab providers strengthen laboratory networks and expand global testing capabilities. The growing focus on personalized medicine and precision therapies continues to fuel demand for high-quality laboratory services, accelerating the industry's significant growth.

Key market players are adopting various strategies to strengthen their market position. These include strategic partnerships, mergers and acquisitions, and expanding laboratory networks to enhance global reach. Companies also invest in advanced technologies such as AI-driven analytics, automation, and biomarker-based testing to improve efficiency and accuracy. For instance, in February 2025, LabConnect entered into a partnership agreement with Sapio Sciences to implement a Laboratory Information Management System (LIMS). This collaboration aims to further digitally transform complex research workflows, streamlining sample tracking and enhancing data management within LabConnect's operations.

Clinical Trial Central Laboratory Services Market Report Highlights:

  • Based on service, biomarker testing services dominated the market due to genomic and molecular testing advancements. Regulatory agencies are also encouraging biomarker-based drug approvals, further fueling the market expansion
  • Based on the phase, Phase III held the largest market share in 2024 due to the high volume of samples and extensive testing requirements. The growing number of late-stage trials and regulatory mandates further drive demand for central lab services
  • Based on Indication, frozen held the largest market share in 2024 due to the rising prevalence of cancer and increasing clinical trials for novel therapies. The growing focus on personalized medicine and biomarker-based diagnostics has amplified the demand for specialized laboratory testing
  • Based on end use, pharmaceutical & biopharmaceutical companies held the largest market share in 2024 due to their high R&D investments and extensive clinical trial pipelines. The increasing demand for specialized testing, biomarker analysis, and precision medicine further strengthened their reliance on central labs
Show more
Product Code: GVR-4-68040-531-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Technological Advancements
    • 3.4.1. Integration of AI and Digital Technologies
  • 3.5. Pricing Model Analysis
  • 3.6. Clinical Trials Volume Analysis, 2024
    • 3.6.1. Total Number of Clinical Trials, by Region (2024)
    • 3.6.2. Total Number of Clinical Trials, by Phase (2024)
    • 3.6.3. Total Number of Clinical Trials, by Study Design (2024)
    • 3.6.4. Total Number of Clinical Trials, by Key Therapeutic Area (2024)
  • 3.7. Industry Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis
    • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Central Laboratory Services Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Clinical Trial Central Laboratory Services Market; Service Movement Analysis
  • 4.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Biomarker Testing Services
    • 4.4.1. Biomarker testing services market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Microbiology Services
    • 4.5.1. Microbiology services market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Anatomic Pathology/Histology
    • 4.6.1. Anatomic pathology/histology market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Pharmacokinetics/Pharmacodynamics (PK/PD)
    • 4.7.1. Pharmacokinetics/Pharmacodynamics (PK/PD) market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.8. Genomic and Molecular Testing
    • 4.8.1. Genomic and molecular testing market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.9. Sample Collection and Processing
    • 4.9.1. Sample collection and processing market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.10. Logistics & Sample Management
    • 4.10.1. Logistics & sample management market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.11. Data Management & Reporting
    • 4.11.1. Data management & reporting market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.12. Others
    • 4.12.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Central Laboratory Services Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Clinical Trial Central Laboratory Services Market; Phase Movement Analysis
  • 5.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Phase, 2018 to 2030 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Central Laboratory Services Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Clinical Trial Central Laboratory Services Market; Indication Movement Analysis
  • 6.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Oncology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Cardiology
    • 6.5.1. Cardiology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Neurology
    • 6.6.1. Neurology market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Infectious Diseases
    • 6.7.1. Infectious Diseases market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Immunology & Autoimmune Diseases
    • 6.8.1. Immunology & autoimmune diseases market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Central Laboratory Services Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Clinical Trial Central Laboratory Services Market; End Use Movement Analysis
  • 7.3. Clinical Trial Central Laboratory Services Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Contract Research Organizations
    • 7.5.1. Contract Research Organizations market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Central Laboratory Services Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Germany clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. UK clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. South Korea clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Australia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Thailand clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait clinical trial central laboratory services market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Position Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Labcorp
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Service benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. ICON plc
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Service benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Eurofins Scientific
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Service benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Thermo Fisher Scientific Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Service benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medpace
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Service benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Q2 Solutions
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Service benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Syneos Health
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Service benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Charles River Laboratories
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Service benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. SGS
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Service benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. LabConnect
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Service benchmarking
      • 9.3.10.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-531-5

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 4 Global Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 5 Global Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 6 Global Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Clinical Trial Central Laboratory Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 10 North America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 11 North America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 12 North America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 14 U.S. Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 15 U.S. Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 16 U.S. Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Canada Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 19 Canada Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 20 Canada Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 Mexico Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 23 Mexico Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 24 Mexico Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 27 Europe Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 28 Europe Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 29 Europe Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 31 UK Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 32 UK Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 33 UK Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 Germany Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 36 Germany Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 37 Germany Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 France Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 40 France Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 41 France Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 Italy Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 44 Italy Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 45 Italy Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 47 Spain Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 48 Spain Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 49 Spain Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 51 Denmark Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 52 Denmark Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 53 Denmark Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 55 Sweden Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 56 Sweden Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 57 Sweden Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Norway Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 59 Norway Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 60 Norway Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 61 Norway Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 68 Japan Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 69 Japan Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 70 Japan Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 72 China Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 73 China Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 74 China Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 76 India Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 77 India Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 78 India Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 80 Australia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 81 Australia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 82 Australia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 84 South Korea Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 85 South Korea Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 86 South Korea Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 88 Thailand Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 89 Thailand Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 90 Thailand Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 93 Latin America Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 94 Latin America Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 95 Latin America Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 97 Brazil Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 98 Brazil Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 99 Brazil Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 101 Argentina Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 102 Argentina Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 103 Argentina Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 104 MEA Clinical Trial Central Laboratory Services Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 MEA Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 106 MEA Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 107 MEA Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 108 South Africa Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 109 South Africa Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 111 South Africa Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 116 UAE Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 117 UAE Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 119 UAE Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait Clinical Trial Central Laboratory Services Market, by Service, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Clinical Trial Central Laboratory Services Market, by Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Clinical Trial Central Laboratory Services Market, by Indication, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Clinical Trial Central Laboratory Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Clinical Trial Central Laboratory Services Market Segmentation
  • Fig. 7 Market Snapshot, 2024
  • Fig. 8 Market Trends & Outlook
  • Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Global Clinical Trial Central Laboratory Services Market: Service Key Takeaways
  • Fig. 14 Global Clinical Trial Central Laboratory Services Market: Service Movement Analysis
  • Fig. 15 Global Clinical Trial Central Laboratory Services Market, for Biomarker Testing Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Clinical Trial Central Laboratory Services Market, for Microbiology Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Clinical Trial Central Laboratory Services Market, for Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Clinical Trial Central Laboratory Services Market, for Pharmacokinetics/Pharmacodynamics (PK/PD), 2018 - 2030 (USD Million)
  • Fig. 19 Global Clinical Trial Central Laboratory Services Market, for Genomic and Molecular Testing, 2018 - 2030 (USD Million)
  • Fig. 20 Global Clinical Trial Central Laboratory Services Market, for Sample Collection and Processing, 2018 - 2030 (USD Million)
  • Fig. 21 Global Clinical Trial Central Laboratory Services Market, for Monitoring & Visibility Solutions, 2018 - 2030 (USD Million)
  • Fig. 22 Global Clinical Trial Central Laboratory Services Market, for Logistics & Sample Management, 2018 - 2030 (USD Million)
  • Fig. 23 Global Clinical Trial Central Laboratory Services Market, for Data Management & Reporting, 2018 - 2030 (USD Million)
  • Fig. 24 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 25 Global Clinical Trial Central Laboratory Services Market: Phase Key Takeaways
  • Fig. 26 Global Clinical Trial Central Laboratory Services Market: Phase Movement Analysis
  • Fig. 27 Global Clinical Trial Central Laboratory Services Market, for Phase I, 2018 - 2030 (USD Million)
  • Fig. 28 Global Clinical Trial Central Laboratory Services Market, for Phase II, 2018 - 2030 (USD Million)
  • Fig. 29 Global Clinical Trial Central Laboratory Services Market, for Phase III, 2018 - 2030 (USD Million)
  • Fig. 30 Global Clinical Trial Central Laboratory Services Market, for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 31 Global Clinical Trial Central Laboratory Services Market: Indication Key Takeaways
  • Fig. 32 Global Clinical Trial Central Laboratory Services Market, Indication Movement Analysis
  • Fig. 33 Global Clinical Trial Central Laboratory Services Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 34 Global Clinical Trial Central Laboratory Services Market, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 35 Global Clinical Trial Central Laboratory Services Market, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 36 Global Clinical Trial Central Laboratory Services Market, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 37 Global Clinical Trial Central Laboratory Services Market, for Immunology & Autoimmune Diseases, 2018 - 2030 (USD Million)
  • Fig. 38 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 39 Global Clinical Trial Central Laboratory Services Market: End Use Key Takeaways
  • Fig. 40 Global Clinical Trial Central Laboratory Services Market, End Use Movement Analysis
  • Fig. 41 Global Clinical Trial Central Laboratory Services Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 42 Global Clinical Trial Central Laboratory Services Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 43 Global Clinical Trial Central Laboratory Services Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 Regional Outlook, 2024 & 2030
  • Fig. 46 North America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 50 Europe Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 51 Germany Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 52 UK Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 53 France Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 55 Spain Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 57 Sweden Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 58 Norway Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 61 China Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 62 India Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 63 Australia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 65 Thailand Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 72 UAE Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait Clinical Trial Central Laboratory Services Market, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!